Latest Features & Opinion
INFECTIONS IN IMMUNOCOMPROMISED PATIENTS
A collection of news, case studies, and feature articles focused on the diagnosis and management of infection processes in patients with immune systems impaired by an underlying disease.
Clostridium difficile is the most common cause of healthcare-associated infections, with as many as 500,000 cases occurring annually in the United States. Efforts to prevent transmission within hospitals typically focus on patients with symptomatic Clostridium difficile infection.
There is an opportunity to improve HCV treatment rates for people who inject drugs by integrating DAA therapy into current models of community-based addiction.
Clinicians should be aware of the possibility of HIV-2 infection in their patients coming from endemic areas, especially West Africa.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Oral Urinary Tract Infection Treatments
- Treating Pseudomonas aeruginosa Infections: Highlights From IDWeek 2018
- Local Gentamicin Application Ineffective in Treatment of Periprosthetic Joint Infection
- High-Dose Influenza Vaccination May Benefit Transplant Recipients
- Update on the Ethics of Mandating HPV Vaccination
- Wildfire Respiratory Protection and Preventing Breathing Problems
- DAA Treatment and Hepatic Fibrosis Improvement in HCV: What's the Link?
- Efficacy of M72/AS01E Tuberculosis Vaccine in Phase 2b Controlled Trials
- Treatment Algorithm Noninferior to Standard Practice for Staphylococcal Bacteremia
- Neonatal Antibody Concentration After Third Trimester Tdap Vaccination